Metabolic
Tirzepatide
About This Compound
Tirzepatide
Tirzepatide 10mg — Research Overview
Tirzepatide is a synthetic dual-agonist peptide engineered for simultaneous co-activation of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. As a benchmark dual-agonist compound, Tirzepatide enables the study of complementary incretin receptor pathway synergy — fundamentally different from single-receptor GLP-1 agonists.
Neogenesis Bio Labs supplies Tirzepatide as a lyophilized peptide at ≥98% purity, verified by third-party HPLC and mass spectrometry analysis.
What Researchers Study Tirzepatide For
- Dual Receptor Co-Activation — simultaneous GIP and GLP-1 receptor pathway studies and synergy characterization
- Insulin Secretion Pathways — glucose-dependent insulinotropic mechanisms and beta-cell function research
- Adipose Tissue Research — fat cell metabolism, lipogenesis inhibition, and adipokine modulation studies
- Glycemic Homeostasis — HbA1c modulation, postprandial glucose excursion, and fasting glucose research
- Body Composition Models — lean mass preservation concurrent with adipose tissue reduction in preclinical settings
- GIP vs. GLP-1 Synergy — comparative research isolating GIP co-activation contribution beyond GLP-1 monotherapy
Frequently Asked Questions
Why does GIP receptor activation matter in Tirzepatide research?
GIP and GLP-1 receptors are expressed in overlapping but distinct cell populations. GIP receptor activation contributes incremental insulin secretion stimulation and adipocyte metabolism effects beyond what GLP-1 alone achieves, allowing researchers to study this additive pathway contribution in a controlled single-compound model.
How does Tirzepatide compare to Semaglutide?
Semaglutide selectively activates GLP-1 receptors. Tirzepatide adds GIP receptor co-activation, producing more pronounced effects on adipose tissue metabolism and glycemic regulation. Tirzepatide serves as the standard dual-agonist reference when comparing single vs. dual vs. triple (Retatrutide) agonist outcomes.
What reconstitution approach is standard?
Lyophilized Tirzepatide is typically reconstituted with bacteriostatic water. Store at or below 4°C and use within 28 days. Store lyophilized powder at 2-8°C prior to reconstitution.
Is a Certificate of Analysis included?
Yes. Every vial ships with a third-party COA confirming compound identity, purity (≥98% HPLC), and peptide integrity.